|
|
Post by jay1ajay1a on Dec 21, 2015 22:14:30 GMT -5
Good grief, this is complete nonsense. Sanofi has spent hundreds of millions of dollars to acquire exclusive rights to distribute Afrezza globally. Per Al Mann they were so eager to have it they started planning before the agreement was even officially signed. Now that real world experience has shown Afrezza to truly be in a class by itself and barely 10 months into what they undoubtedly understood would be a gradual uptake curve "investors" are so desperate they are coming up with nonsense like this? They just announced the discount card program would continue through 2016. They are in the middle of the pediatric trial. Results from that trial will HAVE to show clear superiority if they simply adjust the dosing period to be 15 minutes after the meal begins. SNY must understand that just as they must understand that a label change to clear superiority opens up the floodgates to demand from all sides - doctors and patients - as well as prime insurance coverage. A medication proven to lower HbA1c, hypos, and all the attendant impacts of diabetes such as neuropathy, blindness, etc. will be unmatched in the treatment universe. A label change allowing these statements both in advertising and sales literature - THAT is what they are "waiting for", almost guaranteed. The rollout and introductions will continue, but the massive blitz will not occur until a label change - it is only common sense and smart business. Sanofi is most certainly NOT walking away, nor is anyone else going to get the rights to distribute Afrezza. A proven pharmaceutical giant who has the most effective insulin ever developed and KNOWING they have it does not just walk away after spending hundreds of $millions when they are barely out of the starting gate. They undoubtedly have planned this over a multi-year period, unlike retail investors who find a week to wait until the next Symphony script data an excruciating endeavour. Just face it - the big money in MNKD is going to made over years, not a few more weeks. I'm outta here - too depressing to have to read stuff like this all the time Hang in there and I know your are right we will make big money. Like what you have said! |
|
|
|
Post by dreamboatcruise on Dec 21, 2015 22:16:19 GMT -5
Correct me if I'm wrong, but didn't Matt say they couldn't use the milestone money until they receive a profit from SNY's Afrezza sales? I believe he also said he did not expect to see profits until 2016 or 2017. With sales a slow as they are, it is looking like 2017 will be the earliest MNKD could become profitable from SNY sales. By then MNKD will need a cash infusion. Am I incorrect? Thanks. I'm not sure they were ever totally explicit about the recognizing of the revenue criteria, but I can correct one significant mistake in what you say. The recognition of the money as revenue is what is delayed. They can use the money as soon as received and indeed did use much of the money already received. In a way it hits the balance sheet like a loan since it is shown as an outstanding liability until earned... but just like a loan, a company can use it when received. |
|
|
|
Post by nylefty on Dec 21, 2015 23:00:25 GMT -5
Just face it - the big money in MNKD is going to made over years, not a few more weeks. I'm outta here - too depressing to have to read stuff like this all the time Excellent post. I'm also considering getting outta here....far too much whining! |
|
Deleted
Deleted Member
Posts: 0
|
Post by Deleted on Dec 22, 2015 10:41:42 GMT -5
Kind of weird to realize that all it will take to turn around the MNKD story at this point is about $100m, now that we're pretty sure Afrezza is going to realize it's potential given time. That would have been a mere 10 million shares a few months ago. Now, the dilution path is almost out of reach. OTOH, we know that Al is very sensitive to cash flow and that Matt hasn't been behaving like a CFO in a cash crunch. I certainly agree with the above stated. It seems it would have been a no brainer to do a small offering so as to insure there would be smooth financial sailing all the way till Afrezza was standing on its own. Why was not done that way is just one of the many unanswered questions we have. I guess it is easy to think that all this was done with sound reasons in mind. I wish I could be sure. If they have anything up their sleeve hopefully they drive the price up a bit before doing the offering. Hate using that word |
|
